<!doctype html><html><head><meta charset=utf-8><title>Low risk Prostate Cancer decreased with 4,000 IU of vitamin D</title>
<link rel=stylesheet href="/css/main.css?v=1753303881"><link rel=stylesheet href="/css/pagination.css?v=1753303881"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src="/js/search-suggestions.js?v=1753303881"></script><script src="/js/search.js?v=1753303881"></script><script type=module>
        
        window.initPagefind = async function() {
            try {
                console.log('Loading Pagefind module...');
                window.pagefind = await import('/pagefind/pagefind.js');
                if (!window.pagefind) {
                    throw new Error('Failed to load Pagefind module - import returned empty result');
                }
                
                console.log('Initializing Pagefind...');
                const initResult = await window.pagefind.init();
                console.log('Pagefind loaded and initialized');
                
                
                if (window.searchInstance) {
                    console.log('Notifying Search instance of Pagefind initialization');
                    window.searchInstance.initializePagefind(window.pagefind);
                    console.log('Search instance successfully notified');
                } else {
                    console.warn('Search instance not found in global scope yet, but Pagefind is loaded');
                    
                }
            } catch (error) {
                console.error('CRITICAL ERROR: Failed to initialize Pagefind:', error);
                
                const errorDetails = error.stack || error.message || String(error);
                console.error('Error details:', errorDetails);
                
                
                const statusEl = document.querySelector('#search-status');
                const inputEl = document.querySelector('#search-input');
                
                if (statusEl) {
                    statusEl.textContent = 'Search unavailable: ' + error.message;
                    statusEl.style.display = 'block';
                    statusEl.style.color = 'red';
                }
                
                if (inputEl) {
                    inputEl.disabled = true;
                    inputEl.placeholder = 'Search unavailable';
                }
            }
        };
        
        
        window.pagefindInitialized = false;
        
        
        document.addEventListener('DOMContentLoaded', () => {
            console.log('DOM loaded, initializing Pagefind...');
            window.initPagefind();
        });
    </script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><div class=scroll-nav-top><a href=javascript:void(0); id=scroll-to-bottom class=scroll-button aria-label="Scroll to bottom" onclick='return window.scrollTo({top:document.body.scrollHeight,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 4a.5.5.0 01.5.5v5.793l2.146-2.147a.5.5.0 01.708.708l-3 3a.5.5.0 01-.708.0l-3-3a.5.5.0 11.708-.708L7.5 10.293V4.5A.5.5.0 018 4z"/></svg>
<span>Scroll to Bottom</span></a></div><h1>Low risk Prostate Cancer decreased with 4,000 IU of vitamin D</h1><time>July 7, 2012</time><div data-pagefind-body><h4 id=results-in-a-decrease-of-positive-cores-at-repeat-biopsy-in-subjects-with-low-risk-prostate-cancer-under-active-surveillance>Results in a Decrease of Positive Cores at Repeat Biopsy in Subjects with Low-Risk Prostate Cancer under Active Surveillance</h4><p>The Journal of Clinical Endocrinology & Metabolism July 1, 2012 vol. 97 no. 7 2315-2324</p><p>David T. Marshall, Stephen J. Savage, Elizabeth Garrett-Mayer, Thomas E. Keane, Bruce W. Hollis, Ronald L. Horst, Linda H. Ambrose, Mark S. Kindy and Sebastiano Gattoni-Celli</p><p>Departments of Radiation Oncology (D.T.M., L.H.A., S.G.-C.), Urology (S.J.S., T.E.K.), Medicine (Biostatistics) (E.G.-M.), Pediatrics (B.W.H.), and Neurosciences (M.S.K.), Medical University of South Carolina, Charleston, South Carolina 29425; Ralph H. Johnson Veterans Affairs Medical Center (S.J.S., M.S.K., S.G.-C.), Charleston, South Carolina 29401; and Department of Animal Science (R.L.H.), Iowa State University, Ames, Iowa 50011</p><p>Address all correspondence and requests for reprints to: Sebastiano Gattoni-Celli, M.D., Strom Thurmond Biomedical Research Building, Room 338C, 114 Doughty Street, Charleston, South Carolina 29403. E-mail: <a href=mailto:gattonis@musc.edu>gattonis@musc.edu</a>.</p><p>Context: We wanted to investigate vitamin D in low-risk prostate cancer.</p><p>Objectives: The objective of the study was to determine whether vitamin D3 supplementation at 4000 IU/d for 1 yr is safe and would result in a decrease in serum levels of prostate-specific antigen (PSA) or in the rate of progression.</p><p>Design: In this open-label clinical trial (Investigational New Drug 77,839), subjects were followed up until repeat biopsy.</p><p>Setting: All subjects were enrolled through the Medical University of South Carolina and the Ralph H. Johnson Veterans Affairs Medical Center, both in Charleston, SC.</p><p>Patients and Other Participants: All subjects had a diagnosis of low-risk prostate cancer.</p><p>Fifty-two subjects were enrolled in the study, 48 completed 1 yr of supplementation, and 44 could be analyzed for both safety and efficacy objectives.</p><p>Intervention: The intervention included vitamin D3 soft gels (4000 IU).</p><p>Main Outcome Measures: Adverse events were monitored throughout the study. PSA serum levels were measured at entry and every 2 months for 1 yr.</p><p>Biopsy procedures were performed before enrollment (for eligibility) and after 1 yr of supplementation.</p><p>Results: No adverse events associated with vitamin D3 supplementation were observed.</p><p>No significant changes in PSA levels were observed.</p><p>However,</p><ul><li><p>24 of 44 subjects (55%) showed a <strong>decrease</strong> in the number of positive cores or decrease in Gleason score;</p></li><li><p>five subjects (11%) showed <strong>no change</strong> ;</p></li><li><p>15 subjects (34%) showed an <strong>increase in the number of positive cores or Gleason score</strong> .</p></li></ul><p>Conclusion: <strong>Patients with low-risk prostate cancer under active surveillance may benefit from vitamin D3 supplementation at 4000 IU/d.</strong></p><h5 id=clipped-from-pdf>Clipped from PDF</h5><img src=https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/pc-f3.jpg alt=image>
<img src=https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/pc-f4.jpg alt=image><p>FIG. 4. Trajectories of number of positive cores over time in subjects supplemented with vitamin D3</p><p>(A) and untreated historical control subjects (B). A and B,Gray lines represent</p><p>individual patient data, and thick solid black lines are the fitted estimate including all data</p><p>within 48 months of baseline. The gray circles at the ends of some of thegray lines refer to</p><p>subjects with an increase of Gleason score at repeat biopsy or a decrease of Gleason score</p><p>from baseline. A, The thick solid black lines are the fitted estimates including all data for 24-,</p><p>36-, and 48-month follow-up period, respectively. The slopes are identical between the</p><p>24- and 48-month time thresholds (b0.0146), whereas the slope of the 36-month</p><p>threshold is slightly flatter (0.0125). All corresponding P values are significant: 0.0090 (24</p><p>months); 0.0098 (36 months); 0.00093 (48 months). B, The slope is not significantly different</p><p>from 0 (P0.17). However, the slopes in A and B (based on all follow-up data) are</p><p>significantly different from each other (P0.002).</p></div><hr class=tag-separator><div class=tags><span>Tags: </span><a href=/tags/cancer.html><span class=tag>cancer</span></a>
<a href=/tags/dosage.html><span class=tag>dosage</span></a>
<a href=/tags/intervention.html><span class=tag>Intervention</span></a>
<a href=/tags/prostate-cancer.html><span class=tag>prostate cancer</span></a>
<a href=/tags/prostate-cancer.html><span class=tag>Prostate Cancer</span></a>
<a href=/tags/top-news.html><span class=tag>Top news</span></a>
<a href=/tags/vitamin-d.html><span class=tag>vitamin d</span></a></div><div data-pagefind-meta=tags hidden>cancer, dosage, Intervention, prostate cancer, Prostate Cancer, Top news, vitamin d</div><div class=scroll-nav-bottom id=article-bottom><a href=javascript:void(0); id=scroll-to-top class=scroll-button aria-label="Scroll to top" onclick='return window.scrollTo({top:0,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 12a.5.5.0 00.5-.5V5.707l2.146 2.147a.5.5.0 00.708-.708l-3-3a.5.5.0 00-.708.0l-3 3a.5.5.0 10.708.708L7.5 5.707V11.5a.5.5.0 00.5.5z"/></svg>
<span>Back to Top</span></a></div></article></div></div><script src="/js/toc-sanitizer.js?v=1753303881"></script><script src="/js/tiki-redirects.js?v=1753303881"></script><script src="/js/lightspa.js?v=1753303881"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1753303881",indexUrl:"/search/search_index.json.gz?v=1753303881"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/scroll-buttons.js?v=1753303881"></script></body></html>